Silexion Therapeutics Share Price

SLXN

KYG1281K1489

Market Closed - Nasdaq 02:30:00 14/11/2026 am IST			5-day change	1st Jan Change
1.980 ^USD	-25.56%		-43.18%	-79.07%

22/24/22	Moringa Acquisition Corp Announces Cessation of Ilan Levin as Chief Executive Officer	CI
22/24/22	Moringa Acquisition Corp Announces Cessation of Gil Maman as Chief Financial Officer	CI

Valuation: Silexion Therapeutics

Market Cap	3.26Cr 2.95Cr 2.73Cr 2.46Cr 4.64Cr 307.08Cr 4.81Cr 33Cr 13Cr 164.04Cr 12Cr 12Cr 520.7Cr	P/E 2022	256x	P/E 2023	253x
Enterprise Value	3.53Cr 3.2Cr 2.96Cr 2.67Cr 5.03Cr 332.85Cr 5.21Cr 36Cr 14Cr 177.8Cr 13Cr 13Cr 564.39Cr	EV / Sales 2022	-	EV / Sales 2023	-
Free-Float	-	Yield 2022 *	-	Yield 2023	-

* Estimated data More valuation ratios

Latest news: Silexion Therapeutics

22/24/22	Moringa Acquisition Corp Announces Cessation of Ilan Levin as Chief Executive Officer	CI
22/24/22	Moringa Acquisition Corp Announces Cessation of Gil Maman as Chief Financial Officer	CI
22/24/22	Moringa Acquisition Corp Announces Board Changes	CI
15/24/15	Moringa Acquisition Corp(NasdaqCM:MACA) dropped from NASDAQ Composite Index	CI
15/24/15	Silexion Ltd. completed the acquisition of Moringa Acquisition Corp from Yakira Capital Management, Inc., Linden Capital L.P., Moringa Sponsor, LP and others in a reverse merger transaction.	CI
13/24/13	Moringa Acquisition Corp Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI
16/24/16	Moringa Acquisition Corp Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
02/24/02	Moringa Acquisition Corp Reports Earnings Results for the Full Year Ended December 31, 2023	CI
22/24/22	Silexion Ltd. entered into a business combination agreement to acquire Moringa Acquisition Corp for $68.9 million.	CI
15/23/15	Moringa Acquisition Corp Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
18/23/18	Moringa Acquisition Corp announced that it has received $0.154506 million in funding	CI
15/23/15	Moringa Acquisition Corp Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI
07/23/07	Holisto LTD cancelled the acquisition of Moringa Acquisition Corp from Moringa Sponsor, LP and others.	CI

More news

Press Releases: Silexion Therapeutics

16/24/16	Silexion Therapeutics Ltd. and Moringa Acquisition Corp Announce Closing of their Business Combination	AQ
22/24/22	Silexion, a Clinical-Stage, Oncology-Focused Biotechnology Company, to Become Publicly Traded Via Business Combination with Moringa Acquisition Corp	AQ
15/23/15	MORINGA ACQUISITION CORP ANNOUNCES CONTRIBUTION TO TRUST ACCOUNT IN CONNECTION WITH PROPOSED EXTENSION	AQ
22/23/22	MORINGA ACQUISITION CORP : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	AQ
01/23/01	MORINGA ACQUISITION CORP Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	AQ

More press releases

Managers and Directors: Silexion Therapeutics

Manager	Title	Age	Since
Gil Maman DFI	Director of Finance/CFO	43	24/09/2020

Director	Title	Age	Since
Ruth Alon BRD	Director/Board Member	74	-
Eric Brachfeld BRD	Director/Board Member	-	01/02/2021

More insiders

Moringa Acquisition Corp is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It intends to focus its search on technology-based businesses that are domiciled in Israel, that carry out all or a substantial portion of their activities in Israel, or that have some other significant Israeli connection. It has no operations and generates no revenues.

Employees

Sector

More about the company

Quotes

Date	Price	Change
13/26/13	$1.980	-25.56%
12/26/12	$2.660	-17.65%
11/26/11	$3.230	+23.58%
10/26/10	$2.614	-12.11%
09/26/09	$2.974	-14.67%

Delayed Quote Nasdaq

More quotes

3 years	1.82	13.56
5 years	1.82	13.56
10 years	1.82	13.56

	2022	2023
Net sales	-	-
Net income	6L 5L 5L 4L 8L 5.51Cr 9L 58.8L 23.32L 2.94Cr 21.92L 21.45L 9.34Cr	3L 2L 2L 2L 4L 2.48Cr 4L 26.49L 10.5L 1.33Cr 10L 10L 4.21Cr
Net Debt	11.3L 10.24L 9L 9L 16.11L 11Cr 16.68L 1.14Cr 45.13L 5.69Cr 42.42L 41.52L 18Cr	27.33L 24.76L 22.91L 20.67L 38.95L 26Cr 40.32L 2.75Cr 1.09Cr 14Cr 1.03Cr 1Cr 44Cr

Silexion Therapeutics Share Price

Stocks

SLXN

KYG1281K1489

Valuation: Silexion Therapeutics

Chart: Silexion Therapeutics

Latest news: Silexion Therapeutics

Press Releases: Silexion Therapeutics

Quotes and Performance

Price Extremes

Managers and Directors: Silexion Therapeutics

Latest insider transactions

Financials

Company Profile

Quotes

1 day	-25.56%
Current month	-79.07%
Current year	-79.07%